GlaxoSmithKline Pharmaceuticals Limited — Others, 05-02-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited is facing a GST demand of Rs. 48.13 million from Tamil Nadu authorities for the period July 2017 to March 2018. This includes Rs. 14.93 million in tax, Rs. 18.27 million in interest, and Rs. 14.93 million in penalty, primarily due to discrepancies in GST credit claims. The company has stated that there will be no immediate impact on its financial operations while it evaluates the demand order and considers its response. This situation may create some uncertainty, but currently suggests a neutral impact on investor sentiment.